Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received adjuvant celecoxib in addition to chemotherapy, whereas the ...

特别是在早期非小细胞肺癌（non-small cell lung cancer ... 研究报道“Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma ...

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...

Overall, the platform’s capability to detect ultra-low ctDNA levels holds promise for advancing personalized medicine in early-stage lung cancer.

研究结果表明，利用OTS试验系统来监测ctDNA或能与CGP数据进行有效 ... 近日，一篇发表在国际杂志Cancer Science上题为“Comprehensive Genome Profiling-Initiated ...

National Comprehensive Cancer Network® (NCCN®) Guidelines for colon and rectal cancer were updated to include ctDNA as a prognostic marker and high risk factor for recurrence NCCN guideline for ...

In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant setting, recognizing its prognostic value.

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...